氨氯地平和赖诺普利对高血压病患者肾功能的影响
被引量：1
摘要
众所周知,肾脏是高血压累及的重要靶器官之一,高血压患者发生微白蛋白尿的程度显著高于血压正常者[1,2],微白蛋白尿可作为判定高血压患者肾损害进展的可靠指标[3,4],高血压病患者尿中白蛋白水平增加是心脑血管疾病发生和死亡的独立因素吲。因此，常规的降压治疗能否有效地减轻蛋白尿，保护肾功能值得探讨。业已证明：血管紧张素转换酶抑制剂可减轻高血压肾损害，减少尿蛋白排泄，保护肾功能。
出处
《中国实用医药》
2011年第8期154-156,共3页
China Practical Medicine
参考文献12
-
1Parting HH, Jensen HE, Mogensen CE, et al. Increased urinary albumin excretion in begin essential hypertension. Lancet, 1974, 1 : 231-237.
-
2Giaconi S, Levanti C, Fommei E, et al. Microalbuminuria and cas-ual and ambulatory blood pressure monitoring in normotensives and in patients with borderline and mild essential hypertension. Am J Hypertens, 1989, 2:259-261.
-
3Viberti GC, Hill RD, Jarret RD, et al. Microalbuminuria as a pre- dictor of clinical nephropathy in insulin-dependent diabetes melli-tus. Lancet, 1982, 1:1430-1432.
-
4Mogensen CE. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med, 1986, 310:356-360.
-
5Yudkin JS, Forrest RD, Jackson CA. Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Lancet, 1988, 2:530- 533.
-
6Ruilope LM, Miranda B, Morales JM, et al. Converting euzyme in- hibition in chronic renal failure. Am J Kidney Dis, 1989, 13:120- 126.
-
7Bauer JH, Reams GP. Do calcium antagoists protect the human hy-pertensive kidney Am J Hypertens, 1989, 2:173s-178s.
-
8Bianchi S, Bigazzi R, Baldari G, et al. Micmalbuminuria in pa- tients with essential hypertension : effects of an angiotensin conver- ting enzyme inhibitor and of a calcium channel blocker. Am J Hy- pertens, 1991,4:291-296.
-
9Deen WM, Satvat B. Determinants of the glomerular filtration of proteins. Am J Physiol, 1981, 241:162-164.
-
10Zuchelli P, Zuccala A, Borghi M, et al. Long-term comparison between captopril and nifedipine in the progression of renal insuffi- ciency. Kidney int, 1992, 42:452-458.
同被引文献19
-
1王世喜,刘景妨,刘景艳,王智慧.赖诺普利和左旋氨氯地平治疗高血压的疗效观察[J].当代医学,2008,14(14):18-19. 被引量：5
-
2World Health Organization, International Society of Hypertension Writing Group. 2003 World Health Organization ( WHO )/International Society of Hypertension ( ISH ) statement on management of hypertension[J]. J Hypertens, 2003,21(11):1983- 1992.
-
3中国医师协会.苯磺酸氨氯地平临床应用中国专家建议[A].第八届中国心脑医学沦坛论文集[C].北京:2010:253-261.
-
4Beltman F, Heesen W,Smit A,et al. Two-year follow up study to evaluate the reduction of left ventricular mass and diastolic function in mild to moderate diastolic hypertensive patients [J].J Hypertens Suppl,1998,16(6) :S15 19.
-
5Terpstra WF, May JF, Smit AJ, et al. Long term effects of amlodipine and lisinopril on left ventrieular mass and diastolic function in elderly,previously untreated hypertensive patients: the EI.VERA trial[J]. J Hypertens,2001,19(2) = 303 -309.
-
6Wu SC, Liu CP,Chiang HT, et al. Prospective and randomized study of the antihypertensive effect and tolerability of three antihypertensive agents, losartan, amlodipine, and lisinopril, in hypertensive patients[J]. Heart Vessels,2004,19(1) :13-18.
-
7Fogari R, Zoppi A, Malamani GD, et al. Effects of different antihypertensive drugs on plasma fibrinogen in hypertensive patients[J]. Br J Clin Pharmacol,1995,39(5) :471-476.
-
8Hughes AD, Stanton AV, Jabbar AS, et al. Effect of antihypertensive treatment on retinal microvaseu[ar changes inhypertension[J]. J Hypertens,2008,26(8) : 1703-1707.
-
9Alici G, Aliyev F, Bellur G, et al. Effect of seven different modalities of antihypertensive therapy on pulse pressure in patients with newly diagnosed stage I hypertension[J].Cardiovasc Ther,2009,27(1) :4-9.
-
10Janssen JJ, Gans RO, van der meulen J, et al. Comparison between the effects of amlodipine and lisinopril on proteinuria in nondiabetic renal failure: a double-blind, randomized prospective study[J1. Am J Hypertens, 1998,11(9): 1074- 1079.
-
1郭冀珍,钱文琪,张慧丽,高平进,龚竺生.依那普利对高血压病合并微白蛋白尿患者肾脏的保护作用[J].中国临床药理学杂志,1992,8(2):76-81. 被引量：4
-
2杨瑞平,李妮.老年2型糖尿病人微白蛋白尿与心血管并发症危险因素的关系探讨[J].中华临床医药杂志（北京）,2002,3(2):48-49.
-
3葛祖恺,王明琴,黄志华,周幼珍.巯甲丙脯酸治疗糖尿病伴高血压患者微白蛋白尿变化[J].江苏医药,1993,19(3):160-160.
-
4Carl,EM,庞祥.微白蛋白尿与糖尿病肾病[J].国外医学（内分泌学分册）,1991,11(2):75-76. 被引量：12
-
5胡云,朱大龙,黄洪.2型糖尿病患者微白蛋白尿与血糖、血脂和血尿酸的相关关系[J].山东医药,2000,40(24):35-36. 被引量：7
-
6肖正华,周倩,陈定宇,周峥.调脂治疗对早期糖尿病肾病的影响[J].实用糖尿病杂志,2006,2(4):19-20. 被引量：6
-
7HIV感染与微白蛋白尿间的关系[J].传染病网络动态,2007(7):5-5.
-
8贾英辉,刘盼,王春寒.辛伐他汀与氟伐他汀对高血压肾病患者的疗效[J].临床医药实践,2014,23(4):274-276. 被引量：1
-
9王向军.银杏达莫注射液联合厄贝沙坦治疗早期糖尿病肾病疗效观察[J].实用中医药杂志,2012,28(2):109-110. 被引量：8
-
10傅彬.前列地尔与缬沙坦联合用药治疗早期糖尿病肾病的临床研究[J].贵阳中医学院学报,2013,35(3):69-70. 被引量：7
